Ambeed.cn

首页 / / / / Felodipine/非洛地平

Felodipine/非洛地平 {[allProObj[0].p_purity_real_show]}

货号:A268185 同义名: H 154/82; CGH-869

Felodipine是一种选择性的 L 型钙通道拮抗剂,具有血管选择性。其 IC50 值为 0.15 nM,能够通过作用于血管平滑肌特别是阻力血管来降低血压,具有抗高血压和诱导自噬的活性。

Felodipine/非洛地平 化学结构 CAS号:72509-76-3
Felodipine/非洛地平 化学结构
CAS号:72509-76-3
Felodipine/非洛地平 3D分子结构
CAS号:72509-76-3
Felodipine/非洛地平 化学结构 CAS号:72509-76-3
Felodipine/非洛地平 3D分子结构 CAS号:72509-76-3
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Felodipine/非洛地平 纯度/质量文件 产品仅供科研

货号:A268185 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 Ca2+ channel-like protein Calcium Channel Cav 2.2 其他靶点 纯度
CDC25B-IN-2 Akt 99%+
Clevidipine 97%
Verapamil HCl 99%
Amlodipine 99%
Amlodipine maleate 98%
(+)-cis-Diltiazem HCl 99%
Zegocractin ++

Orai1/STIM1-mediated Ca2+ currents, IC50: 120 nM

99%+
Tanshinone IIA sulfonate sodium 98%
Ulixacaltamide ++

hCaV3.1, IC50: 50 nM

hCaV3.2, IC50: 110 nM

99%+
Dronedarone HCl 95%
Nitrendipine +

Calcium channel, IC50: 95 nM

98%
Efonidipine HCl monoethanolate 98%
Cinnarizine 98%
SEA0400 ++

NCX, IC50: 33 nM

ERK,ROS,p38 MAPK 99%+
Fasudil HCl PKA,Rho 98%
ML-9 Akt,MLCK 99%+
Flunarizine 2HCl +

Calcium channel, Ki: 68 nM

95%
Lomerizine 2HCl 98%
Efonidipine 98%
Levamlodipine 98%
Nisoldipine ++

L-type Cav1.2, IC50: 10 nM

97%
Isradipine 98%
Lacidipine 98%
Lercanidipine 99%
Loureirin B Potassium Channel 99%+
Tetracaine HCl 98%
Manidipine +++

Calcium channel, IC50: 2.6 nM

99%
Manidipine Dihydrochlorid +++

Calcium channel, IC50: 2.6 nM

98%
Nicardipine 99%
Wilforgine 98+%
Econazole 99%+
Ginsenoside Rd NF-κB 98%
Fendiline HCl 98+%
Mesaconitine 98%
Tetrandrine 95%
Nifedipine 98%
Nilvadipine ++++

Calcium channel, IC50: 0.03 nM

95%
Barnidipine ++++

[3H]nitrendipine, Ki: 0.21 nM

95+%
Azelnidipine 97%
Levetiracetam 98%
Nimodipine 95%
Benidipine HCl 98%
Pinaverium bromide 98%
Pranidipine 99%
NP118809 +

L-type calcium channel, IC50: 12.2 μM

N-type Ca2+ channel, IC50: 0.11 μM

95%
Amlodipine Besylate +++

Calcium channel, IC50: 1.9 nM

97%
Cilnidipine 99%
Cinepazide Maleate 99% (HPLC)
Terfenadine 98%
YM-58483 99%+
Amiloride HCl 98%
Ranolazine 98%
Praeruptorin A Akt,p38 MAPK 98%
Ranolazine 2HCl 98%
Felodipine ++++

L-type calcium channel, IC50: 0.15 nM

98%
PD173212 +++

N-type Ca2+ channel, IC50: 36 nM

98%
Levamlodipine besylate 97%
Carboxyamidotriazole Orotate 98%
IGS-1.76 98+%
WH-4-023 ++++

Cav 2.2, IC50: 0.001 μM

++++

Cav 2.2, IC50: 0.001 μM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Felodipine/非洛地平 生物活性

靶点
  • Calcium Channel

    L-type calcium channel, IC50:0.15 nM

描述 Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker. Felodipine significantly relaxes KCl-contracted porcine coronary segments by blocking the Ca2+ channels, displaying ~50 times more potent than nifedipine (IC50 of ~8 nM) and ~430 times than verapamil (IC50 of ~65 nM) [3]. Felodipine significantly induces the transcription and secretion of IL-6 and IL-8 with ED50 values of 5.8 nM and 5.3 nM in primary human VSMC and lung fibroblasts, respectively, while propranolol or furosemide fails to affect the expression of the two IL genes[4]. Felodipine blocks the muscarinic receptor-mediated (carbachol) Ca2+-dependent contraction of guinea pig ileum longitudinal smooth muscle (GPILSM) with an IC50 of 1.45 nM[5]. In hypertensive patients, felodipine does not appear to significantly affect glomerular filtration rate, creatinine clearance, glucose tolerance, or plasma lipoprotein concentrations. In the management of hypertension, felodipine 5-40 mg/d significantly reduces systolic and diastolic BP. Adverse effects associated with felodipine are similar to those of other dihydropyridine calcium-channel antagonists and include peripheral edema, headache, dizziness, flushing, and fatigue. Felodipine appears to be safe and effective for the management of hypertension when used alone or in combination with other antihypertensive agents[6].

Felodipine/非洛地平 细胞实验

Cell Line
Concentration Treated Time Description References
IPSC-derived human neurons 100 nM 5 days Felodipine reduced levels of A53T α-synuclein. Nat Commun. 2019 Apr 18;10(1):1817.
MRSE (ATCC 35984) 8 μg/mL 24 hours Evaluate the antibacterial effect of felodipine on MRSE, results showed that felodipine could effectively inhibit the growth of MRSE. Bioact Mater. 2021 Nov 24;14:272-289.
MRSA (ATCC 43300) 8 μg/mL 24 hours Evaluate the antibacterial effect of felodipine on MRSA, results showed that felodipine could effectively inhibit the growth of MRSA. Bioact Mater. 2021 Nov 24;14:272-289.
Brain tissue 1.0 nM 30 minutes Measure the effect of Felodipine on [3H]-isradipine binding in brain tissue. Results showed that Felodipine significantly inhibited [3H]-isradipine binding. Br J Pharmacol. 1994 Aug;112(4):1017-24.
LL29 cells 6 µM and above 48 hours Inhibited TGF-β1-induced collagen production without affecting cell viability Sci Rep. 2017 Jun 13;7(1):3439.
Mouse primary cortical neurons 1 µM and 5 µM 5 hours Felodipine increased LC3-II levels, indicating enhanced autophagic flux. Nat Commun. 2019 Apr 18;10(1):1817.

Felodipine/非洛地平 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Spontaneously hypertensive rats (SHR) Spontaneously hypertensive rat model Subcutaneous osmotic minipump 0.4 mg/kg/day Once daily for four weeks Felodipine monotherapy decreased systolic blood pressure. The combination with ramipril was more effective than ramipril alone but not significantly better than felodipine monotherapy. The beneficial effect of felodipine monotherapy on left ventricular hypertrophy was less prominent than that of ramipril, but its cardioprotective effect was improved when combined with ramipril. Br J Pharmacol. 1997 Jun;121(3):503-10
Mice Ethanol dependence model Intraperitoneal injection 10 mg/kg Single dose Evaluate the effect of Felodipine on the ethanol withdrawal syndrome. Results showed that Felodipine did not significantly alter the behavioral manifestations of ethanol withdrawal. Br J Pharmacol. 1994 Aug;112(4):1017-24.
CD1 ICR mice Skin and soft tissue infection model Subcutaneous injection 20 mg/kg and 40 mg/kg Every 24 hours for 7 days Evaluate the antibacterial effect of felodipine in a murine skin and soft tissue infection model, results showed that high-dose felodipine significantly reduced fluorescence intensity and bacterial burden at the infection site. Bioact Mater. 2021 Nov 24;14:272-289.
ICR mice Bleomycin-induced pulmonary fibrosis model Intratracheal administration 3.3 mg/kg Once daily for 14 days Prevented and treated bleomycin-induced pulmonary fibrosis, improved lung function and reduced collagen deposition Sci Rep. 2017 Jun 13;7(1):3439.
Mice B6HD (N171-82Q) mice Intraperitoneal injections 5 mg/kg Three times a week for 6 weeks Felodipine improved motor performance and reduced huntingtin aggregate numbers in B6HD mice. Nat Commun. 2019 Apr 18;10(1):1817.
Mice P301S transgenic mice (PS19) Intraperitoneal injection 5 mg/kg Daily for 14 days Felodipine significantly attenuated tau-mediated microglial activation and NLRP3 expression, and significantly reduced tau hyperphosphorylation at S202/Thr205 and Thr212/Ser214 residues by inhibiting JNK/P38 signaling. Mol Brain. 2024 Sep 2;17(1):62
Wistar-Kyoto rats Fructose-fed rat model Intubation 5 mg/kg/day Once daily for 6 weeks Felodipine significantly attenuated the increased levels in serum IL-18 and cardiac IL-18 mRNA as well as coronary perivascular fibrosis in fructose-fed rats. Mol Med. 2008 Jul-Aug;14(7-8):395-402

Felodipine/非洛地平 参考文献

[1]Yiu S, Knaus EE. Synthesis, biological evaluation, calcium channel antagonist activity, and anticonvulsant activity of felodipine coupled to a dihydropyridine-pyridinium salt redox chemical delivery system. J Med Chem. 1996 Nov 8;39(23):4576-82.

[2]Rodler S, Roth M, Nauck M, et al. Ca(2+)-channel blockers modulate the expression of interleukin-6 and interleukin-8 genes in human vascular smooth muscle cells. J Mol Cell Cardiol. 1995 Oct;27(10):2295-302.

[3]Johnson JD, Fugman DA. Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments. J Pharmacol Exp Ther. 1983;226(2):330‐334

[4]Rödler S, Roth M, Nauck M, Tamm M, Block LH. Ca(2+)-channel blockers modulate the expression of interleukin-6 and interleukin-8 genes in human vascular smooth muscle cells. J Mol Cell Cardiol. 1995;27(10):2295‐2302

[5]Yiu S, Knaus EE. Synthesis, biological evaluation, calcium channel antagonist activity, and anticonvulsant activity of felodipine coupled to a dihydropyridine-pyridinium salt redox chemical delivery system. J Med Chem. 1996;39(23):4576‐4582

[6]Yedinak KC, Lopez LM. Felodipine: a new dihydropyridine calcium-channel antagonist. DICP. 1991;25(11):1193‐1206

Felodipine/非洛地平 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.60mL

0.52mL

0.26mL

13.01mL

2.60mL

1.30mL

26.02mL

5.20mL

2.60mL

Felodipine/非洛地平 技术信息

CAS号72509-76-3
分子式C18H19Cl2NO4
分子量 384.25
SMILES Code O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC(Cl)=C2Cl)OCC
MDL No. MFCD00868316
别名 H 154/82; CGH-869; Felodipine, Agon, Felo-Puren, Felobeta, Felocor, Felodipin, Felodur Felogamma, Fensel, Flodil, Modip, Munobal, Perfudal, Plendil, Renedil
运输蓝冰
InChI Key RZTAMFZIAATZDJ-UHFFFAOYSA-N
Pubchem ID 3333
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 105 mg/mL(273.26 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。